References
- Prescott, L. F. (1996). Paracetamol: A Critical Bibliographic Review. Taylor & Francis, London.
- Koch, P. A., Schultz, C. A., Wills, R. J., Hallquist, S. L. and Welling, P. G. (1978). Influence of food and fluid ingestion on aspirin bioavailability. J. Pharm. Sci., 67, 1533–1555.
- Mattok, G. L. and McGilveray, I. J. (1973). The effect of food intake and sleep on the absorption of acetaminophen. Rev. Can. Biol., 32, S77–S84.
- Walter-Sack, I. E., de Vries, J. X., Mickel, B., Stenzhorn, G. and Weber, E. (1989). The influence of different formular diets and different pharmaceutical formulations on the systemic availability of paracetamol, gallbladder size and plasma glucose. Int. J. Pharmacol. Ther. Toxicol., 27, 544–550.
- Vane, J. R. and Botting, R. M. (1992). Aspirin and Other Salicylates. Chapman & Hall, London.
- Muir, N., Nichols, J. D., Stillings, M. R. and Sykes, J. (1997). The influence of dosage form on aspirin kinetics: implications for acute cardiovascular use. Curr. Med. Res. Opin., 13(10), 547–553.
- Muir, N., Nichols. J. D., Clifford, J. M., Stillings, M. R. and Hoare, R. C. (1997). Comparative bioavailability of aspirin and paracetamol following single dose administration of soluble and plain tablets. Curr Med Res Opin., 13(9), 491–500.
- Wessels, J. C., Koeleman, H. A., Boneschans, B. and Steyn, H. S. (1992). The influence of different types of breakfast on the absorption of paracetamol among members of an ethnic group. Int. J. Cl. Pharmacol. Ther Toxicol., 30, 208–213.
- Endrenyi, L., Fritsch, S. and Yan, W. (1991). Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence. Int. J. Cl. Pharmacol. Ther. Toxicol., 29, 394–399.
- Edwardson, P. A., Nichols, J. D. and Sugden, K. (1989). Application of a modified colormetric enzyme assay to monitor plasma paracetamol levels following single oral doses to non-patient volunteers. J. Pharm. Biomed. Anal., 7, 287–293.
- Needs, C. J. and Brooks, P. M. (1989). Clinical pharmacokinetics of salicylates. Clin. Pharmacokinet., 10, 164–167.
- Brune, K. (1988) The pharmacological profile of non-opioid (OTC) analgesics: aspirin, paracetamol (acetaminophen), ibuprofen and phenazones. Agents Actions, 25, S9–S19.
- Jaffe, J. M., Colaizzi, J. L. and Barry, H. (1971). Effects of dietary components on GI absorption of acetaminophen tablets in man. J. Pharm. Sci., 60, 1646–1650.
- McGilveray, I. J. and Mattock, G. L. (1972). Some factors affecting the absorption of paracetamol. J. Pharm. Pharmacol., 24, 615–619.
- Dollery, C. (1999). Acetaminophen monograph. In: Therapeutic Drugs, 2nd edn, Churchill Livingstone, London, A19–A21.
- Jackson, C. H., MacDonald, N. C. and Cornett, J. W. (1984). Acetaminophen: a practical pharmacologic overview. Can. Med. Assoc. J., 131, 25–32,37.
- Dollery, C. (1999). Acetaminophen monograph. In: Therapeutic Drugs, Churchill Livingstone, London, 2nd edn, A216–A221.
- Bloomfield, S. S., Barden, T. P. and Mitchell, J. (1981). A comparison of pirprofen, aspirin, acetaminophen and placebo in post partum uterine cramp pain. Curr. Ther. Res., 30, S139–S145.
- Peters, B. H., Fraim, C. J. and Masel, B. E. (1983). Comparison of 650 mg aspirin and 1000 mg acetaminophen with each other and placebo in moderately severe headache. Am. J. Med., 74, 36–42.
- Inset, P. A. (1996). Analgesic, antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In Hardman, J. F. and Limbird, L. E. (Eds), The Pharmacological Basis of Therapeutics, 9th edn, McGraw-Hill, London, p. 610.